NCT01488591
Unknown
Not Applicable
Biomarker Research for Personalized Medicine in Blood Cancer Patient
ConditionsHematologic Neoplasms
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hematologic Neoplasms
- Sponsor
- Inje University
- Enrollment
- 1000
- Locations
- 1
- Last Updated
- 12 years ago
Overview
Brief Summary
The aim of this study :
- Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment
- Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping
Investigators
Jae-Gook Shin
Department of Pharmacology and Pharmacogenomics Research Center
Inje University
Eligibility Criteria
Inclusion Criteria
- •Clinical diagnosis of Hematologic neoplasms
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's SyndromeHealthySicca SyndromeSjögren's SyndromeNCT02422407Biogen100
Completed
Not Applicable
Investigation of Specific Protein/Markers in Patients With Osteoarthritis of the Knee Having a Total Knee ReplacementOsteoarthritis of the KneeNCT01611441AstraZeneca125
Unknown
Not Applicable
Diagnostic, Risk Stratification and Prognostic Value of Novel Biomarkers in Patients With Heart FailureHeart FailureNCT03727828Shanghai 10th People's Hospital3,000
Recruiting
Not Applicable
Genetic Biomarker Research for Personalized Therapy of Chorioretinal Neovascular DiseasesDiseases of the eye and adnexaKCT0001055Inje University Busan Paik Hospital1,000
Completed
Not Applicable
Research of Biomarkers in Duchenne Muscular Dystrophy PatientsDuchenne Muscular Dystrophy (DMD)NCT01380964Genethon220